Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments: 2012-2024

Historic Change in Acquisitions & Divestments for Amphastar Pharmaceuticals (AMPH) over the last 10 years, with Dec 2024 value amounting to $126.0 million.

  • Amphastar Pharmaceuticals' Change in Acquisitions & Divestments rose 327.94% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.3 million, marking a year-over-year decrease of 31.28%. This contributed to the annual value of $126.0 million for FY2024, which is 226.30% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Change in Acquisitions & Divestments of $126.0 million as of FY2024, which was up 226.30% from $38.6 million recorded in FY2023.
  • Amphastar Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $126.0 million for FY2024, and its period low was $12.4 million during FY2020.
  • For the 3-year period, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments averaged around $64.2 million, with its median value being $38.6 million (2023).
  • Data for Amphastar Pharmaceuticals' Change in Acquisitions & Divestments shows a peak YoY surged of 226.30% (in 2024) over the last 5 years.
  • Over the past 5 years, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments (Yearly) stood at $12.4 million in 2020, then soared by 51.24% to $18.8 million in 2021, then soared by 49.00% to $28.0 million in 2022, then soared by 38.09% to $38.6 million in 2023, then skyrocketed by 226.30% to $126.0 million in 2024.